Recently, Flow Pharma posted a press release about FlowVax, their therapeutic cancer vaccine technology:
“In order to make a personalized therapeutic cancer vaccine, you have to know the genomic information of the patient’s tumor as well as that of the patient. Speed and accuracy are both critical. Once we have these gene sequences, we can use AI-augmented bioinformatics tools to quickly identify tumor targets for T-cell attack and then rapidly load these targets into a FlowVax vaccine customized for that particular patient.”
I'm very excited to see a long-term client making such great progress, and I look forward to helping them in the future. For those who want to learn more, you can check out the video they've posted to their website about the technology:
http://www.flowpharma.com/uploads/b/108411379-466361156151520728/flow_pharma_narrated_deck_316.mp4
